Trials / Withdrawn
WithdrawnNCT03586232
Arnica Montana and Bromelain in Rhinoplasty
Effects of Arnica Montana and Bromelain in Rhinoplasty
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Boston Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the perioperative use of Arnica Montana and the combined use of Arnica Montana and Bromelain in aiding the body's wound healing functions during the postoperative period after rhinoplasty. The secondary objective of the study is to determine if there is a reduction in postoperative edema when Arnica Montana and Bromelain are combined. Another secondary objective is to demonstrate increased patient satisfaction with the use of Arnica Montana and the combination Arnica Montana and Bromelain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Arnica Montana | Arnica Montana is from the Asteraceae plant family and is native to the mountain areas in Europe and western North America. It is reported to have anti-inflammatory, antiseptic, and vasodilatory properties and is often used in plastic surgery to help reduce pain, edema, and ecchymosis postoperatively. |
| DIETARY_SUPPLEMENT | Bromelain | Bromelain is a protease enzyme derived from the pineapple plant, Ananas comosus, which has been used to reduce swelling, inflammation, and pain and may help to reduce wound healing time. |
| OTHER | Placebo | A pharmacologically inert preparation |
Timeline
- Start date
- 2019-08-01
- Primary completion
- 2020-08-01
- Completion
- 2020-08-01
- First posted
- 2018-07-13
- Last updated
- 2019-08-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03586232. Inclusion in this directory is not an endorsement.